SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Sakar Healthcare Ltd

BSE: 0 NSE: SAKAR ISIN: INE732S01012
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Sakar Healthcare Ltd belong to?
Sakar Healthcare Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Sakar Healthcare Ltd a good quality company?
Sakar Healthcare Ltd is a average quality company, based on a somewhat consistent 10 year financial track record.
Q.3 Is Sakar Healthcare Ltd undervalued or overvalued?
Sakar Healthcare Ltd appears Overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Sakar Healthcare Ltd a good buy now?
Sakar Healthcare Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Sakar Healthcare Ltd?
Sakar Healthcare Ltd revenue growth is 15.8% for FY-2025 , which is below its 5 year CAGR of 16.4% , indicating slower growth.
Q.2 Gross Profit margin of Sakar Healthcare Ltd?
Sakar Healthcare Ltd Gross profit margin which is the profit after deduction of direct costs, is 24.1% for FY-2025 , which is above its 5 year median of 22.5% , indicating increasing margins.
Q.3 Operating Profit Margin of Sakar Healthcare Ltd?
Sakar Healthcare Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 28.18% for FY-2025 , which is above its 5 year median of 24.94% indicating increasing margins.
Q.4 Net Profit Margin of Sakar Healthcare Ltd?
Sakar Healthcare Ltd Net Profit Margin is 9.86% for FY-2025 , is in line with with its 5 year median of 9.86%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin 24.1 22.5
Operating Profit Margin 28.18 24.94
Net Profit Margin 9.86 9.86
Q.5 Return on Asset of Sakar Healthcare Ltd?
Sakar Healthcare Ltd Return on Asset is 4.35%, which is in line with its 5 year historical median of 4.35%, indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of Sakar Healthcare Ltd?
Sakar Healthcare Ltd Return on equity is 6.48% for FY-2025 , which is below its historical median of 8.48%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Sakar Healthcare Ltd?
Sakar Healthcare Ltd Return on capital employed is 8.52% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Sakar Healthcare Ltd?
Sakar Healthcare Ltd Cash conversion cycle is 70 days, above its historical median of 28 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.44 0.44
ROE 6.48 8.48
ROCE 8.52 8.95
Cash Conversion Cycle 70 days 28 days
Q.9 Debt to Equity ratio of Sakar Healthcare Ltd?
Sakar Healthcare Ltd Debt-to-Equity ratio is 0.31 , which is above with the industry average of 0.15 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Sakar Healthcare Ltd?
Sakar Healthcare Ltd Debt to cash flow from operations is 2.54 , which is at a moderate level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Sakar Healthcare Ltd?
Promoters hold 52.86% of the Sakar Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Sakar Healthcare Ltd vs industry peers?
Sakar Healthcare Ltd revenue CAGR is 16.44% , compared to the industry median CAGR of 5.54% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 177.6 137.1
Gross Profit 42.9 15.1
Operating Profit 50 16
Net Profit 18 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.44 0.8
ROE 6.48 8.91
ROCE 8.52 11.59
Cash Conversion Cycle (days) 70.31 76

Valuation & price assessment

Q.1 Stock return of Sakar Healthcare Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 39.56% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - 39.6% 38.6% 104%
Q.3 Valuation ratios of Sakar Healthcare Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 52.07 55.41 40.28
Price to Book 4.19 2.99 2.77
Price to Sales 5.69 4.90 2.65
EV to EBITDA 22.82 20.60 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Natco Pharma
10. Eris Lifesciences
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×